Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Piracetam

A cyclic derivative of GABA synthesised in 1964 by the Romanian psychologist and chemist Corneliu Giurgea, who was studying analogues of this neurotransmitter in the 1960s. In Europe it is approved for myoclonus, sudden involuntary muscle jerks. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?To describe its effects, Giurgea coined the term nootropic in 1972, from the Greek words for mind and to turn.

PiracetamGo to the active ingredient →
PiracetamActive ingredientPiracetamCat. No. P-P129-001CAS 7491-74-9
Piracetam-d6Isotopically labelledPiracetam-d6Cat. No. P-P129-007CAS 2907016-93-5
Piracetam-d8Isotopically labelledPiracetam-d8Cat. No. P-P129-008CAS 1329799-64-5

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Reference substancePiracetam CRSEDQM code Y0000288Family Piracetam

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.